Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neuraly, Inc.
Age
30–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who are diagnosed with Parkinson's disease according to UK Parkinson's Disease Society Brain Bank Clinical Diagnostic criteria or Movement Disorder Society Research Criteria
Patients with Parkinson's disease according to protocol specified scale assessments
DaTscan consistent with diagnosis of Parkinson's Disease
Men or women 30 to 80 years of age
You may not be if
Diagnosis of secondary or atypical parkinsonism
Prior use of dopaminergic treatment or MAO-B inhibitors for more than 28 days
Medical or recreational use of marijuana or THC-containing compounds within 3 months of screening visit
Pregnant or planning to become pregnant
Metabolic, surgical, psychiatric or laboratory abnormality that would interfere with study compliance or safety in the judgment of the investigator
Clareo Health | A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
